pharma · Small Cell Lung Cancer · Metastatic castration-resistant prostate cancer (mCRPC)
Amgen
Amgen clinical programs — 26 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- One Amgen Center Drive, Thousand Oaks, CA 91320, US
- Founded
- 1980
- Employees
- 40,212
- Programs
- 96
- Drugs
- 124
- Patents
- 25
Amgen projects
26 ClinicalTrials.gov programs sponsored by Amgen.
Amgen has 26 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
20170104
Amgen
Ulcerative Colitis (UC)
1 trial -
20180257
Amgen
Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) and Minimal Residual Disease Positive (MRD+) B-ALL,
1 trial -
20200491
Amgen
Relapsed/Refractory Small Cell Lung Cancer
1 trial -
20210023
Amgen
Advanced MTAP-null solid tumors
1 trial -
20210210
Amgen
Ulcerative Colitis (UC)
1 trial -
20220127
Amgen
In Part 1, subjects with advanced MTAP-null solid tumors and, in Part 2, subjects with advanced MTAP-null Non Small-Cell Lung Cancer
1 trial -
20230302
Amgen
Thyroid Eye Disease
1 trial -
20240092
Amgen
Small Cell Lung Cancer (SCLC)
1 trial -
AMG 133, Placebo for AMG 133
Amgen
Overweight and Obesity
1 trial -
AMG 193
Amgen
Non-Small Cell Lung Cancer
1 trial -
AMG 732
Amgen
Thyroid Eye Disease
1 trial -
Anvumetostat
Amgen
Advanced MTAP-null Solid Tumors
1 trial -
Apremilast
Amgen
Palmoplantaris Pustulosis
1 trial -
Bemarituzumab
Amgen
Solid tumours
1 trial -
Blinatumomab
Amgen
B Precursor Acute Lymphoblastic Leukemia
1 trial -
Blinatumomab SC2
Amgen
Relapsed/Refractory (R/R) and Minimal Residual Disease Positive (MRD+) B-Cell Precursor Acute Lymphoblastic Leukemia
1 trial -
Daxdilimab
Amgen
Lupus Nephritis
1 trial -
Efavaleukin alfa
Amgen
Ulcerative Colitis
1 trial -
Placebo for AMG 133, AMG 133
Amgen
Type 2 Diabetes Mellitus
1 trial -
Placebo for AMG 451, Rocatinlimab
Amgen
Moderate-to-severe Asthma
1 trial -
Rocatinlimab
Amgen
Asthma
1 trial -
SOTORASIB
Amgen
Non-small cell lung cancer (NSCLC)
1 trial -
SOTORASIB
Amgen
KRAS p.G12C Mutant Advanced Solid Tumors
1 trial -
Tarlatamab
Amgen
Relapsed/Refractory Small Cell Lung Cancer
1 trial -
Uplizna 100 mg concentrate for solution for infusion
Amgen
Immunoglobulin G4 related Disease (IgG4-RD)
1 trial -
Uplizna 100 mg concentrate for solution for infusion
Amgen
Generalized Myasthenia Gravis
1 trial
Frequently asked questions
How many clinical projects does Amgen have?
26 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.